A critical pathological hallmark of Alzheimer?s disease (AD) is plaque deposits in the brain composed of aggregates of the small hydrophobic ?-amyloid (A?) peptide. It is well known that the 38-42 amino acid A? peptides at the crux of the prevalent ?Amyloid Hypothesis? of AD pathogenesis are generated by sequential proteolytic cleavages of the transmembrane ?-Amyloid precursor protein (APP). Two distinct proteolytic cascades lead to amyloidogenic versus non-amyloidogenic fates . Moreover, multiple pathogenic AD mutations alter the flux through these proteolytic pathways by unknown mechanisms. The lack of suitable assays to control or detect proteolysis of APP has both hindered the understanding of how proteolysis is regulated and the development of receptor specific modulators. We have recently developed a synthetic Notch proteolysis assay (SNAPS) that harnesses the easy to control inputs and outputs of Notch signaling to study proteolysis of diverse cell surface receptors by constructing receptor-of-interest/Notch chimeras. We will use this assay to study mechanism and find modulators of APP proteolysis.
Aim 1 : Determine how cellular environment, molecular environment and Alzheimer?s disease mutations affect APP proteolysis.
Aim 2 : Discover APP proteolytic modulators. We will identify nanobodies and single chain antibodies that bind to APP and potentially modulate its proteolysis into A? .

Public Health Relevance

A critical pathological hallmark of Alzheimer?s disease (AD) is plaque deposits in the brain composed of aggregates of the small hydrophobic ?-amyloid (A?) peptide. The A? peptide is a small fragment of a large receptor called Amyloid Precursor Protein that resides on the surface of neurons that is released when proteins called proteases cut it. However a third protease can often cut this fragment in half so that the toxic A? does not form. Our proposal aims to use a new assay we developed in our lab to understand the contexts in which the proteases that generate A? cut and if it is possible to alter this pathway so that the protective protease cuts instead.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Unknown (R35)
Project #
3R35GM119483-05S1
Application #
10123650
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Sammak, Paul J
Project Start
2016-07-20
Project End
2021-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Biochemistry
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Lovendahl, Klaus N; Hayward, Amanda N; Gordon, Wendy R (2017) Sequence-Directed Covalent Protein-DNA Linkages in a Single Step Using HUH-Tags. J Am Chem Soc 139:7030-7035